DENTSPLY SIRONA Inc (NASDAQ: XRAY) shares recently traded at $41.44, surpassing the average analyst 12-month target price of $41.22. This milestone prompts potential analyst reassessments, as there are varying target estimates ranging from a low of $37.00 to a high of $47.00, with a standard deviation of $3.83.
Currently, among nine analysts covering the stock, the ratings breakdown shows three strong buy, one buy, and six hold ratings, while no sell ratings were assigned. The average rating stands at 2.25, indicating a generally favorable outlook despite a slight decline from 2.32 in the past months. Investors are encouraged to evaluate if the stock’s price can continue its upward momentum or if it’s approaching overvaluation.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
